Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-05-05 00:00:00 ET · period of report 2025-05-02 · accession 0001415889-25-012058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-05 | 2025-05-02 | TVTX | Dube Eric M | CEO, Dir | M - OptEx | — | +18.9K | 438.1K | +5% | — |
| D | 2025-05-05 | 2025-05-05 | TVTX | Dube Eric M | CEO, Dir | S - Sale+OE | $21.05 | -18.9K | 419.2K | -4% | -$398.4K |
| D | 2025-05-05 | 2025-05-02 | TVTX | Dube Eric M | CEO, Dir | M - OptEx | $0.00 | -18.9K | 18.9K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-02 | M | A | 18,924 | — | 438,097 | D | — | — | (F2) Each performance-based restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer. |
| 2 | Common | Common Stock | 2025-05-05 | S | D | 18,924 | $21.05 | 419,173 | D | — | — | |
| 3 | Derivative | Performance-based restricted stock units | 2025-05-02 | M | D | 18,924 | $0.00 | 18,924 | D | — · — to — | 18,924 Common Stock | (F2) Each performance-based restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer. (F1) On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 37,848 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. |